Objective: The objective of this study was to compare demographic and clinical events in three groups of preterm neonates: those with necrotizing enterocolitis totalis (NEC-T), those with NEC non-totalis (NEC non-T) and in preterm patients without NEC.
Introduction
Necrotizing enterocolitis (NEC) is the most common cause of significant gastrointestinal (GI) morbidity and mortality in the preterm population. [1] [2] [3] [4] [5] The incidence of NEC has not changed significantly over time because of increasing numbers of premature deliveries. 3 It currently affects approximately 5-10% in very low birth weight infants. 3, 6, 7 Diagnostic and clinical management strategies have remained largely unaltered. Several prophylactic agents have been studied on a small scale to decrease the incidence of NEC, but few have been proven effective. [8] [9] [10] [11] [12] [13] Various studies have been undertaken to elucidate risk factors for the development of NEC. [14] [15] [16] [17] [18] The two most commonly observed risk factors appear to be prematurity and enteral feeding. The use of breast milk may be a protective factor. [19] [20] [21] A particularly aggressive variant, necrotizing enterocolitis totalis (NEC-T), defined in our study as intestinal necrosis greater than 80%, remains largely unstudied. It has been postulated that NEC-T may represent a different category of GI disease. Clinically, its onset is rapid and is almost universally fatal within a very short time.
Subjects and methods

Study subjects
Study patients were identified from the Yale Newborn Special Care Unit, Yale Pediatric Surgery and Pediatric Pathology clinical databases from January 1991 through December 2007. They were of 36 weeks gestational age (GA) at birth or younger with NEC-T or NEC non-T. Infants born with GI anomalies were excluded. Patients, with NEC, who presented with a rapidly declining clinical course similar to NEC-T patients, but who did not have surgery or autopsy (N ¼ 4) were also excluded.
Methods
The study was performed with a retrospective case-control design. The NEC-T case group was matched to two control groups: Group I controls had NEC non-totalis (NEC non-T) and Group II controls did not have a diagnosis of NEC. Each NEC-T case was matched with two to four Group I and Group II controls. NEC-T cases (N ¼ 39) were defined as those patients with a diagnosis of NEC who had surgery or autopsy that revealed X80% necrosis of the intestinal tract. NEC non-T patients were designated as control group I (N ¼ 148) and had a diagnosis of NECXStage II. They were matched to cases by GA at birth within 2 weeks and by date of NEC presentation within 6 months of the matched case. Group II controls (N ¼ 110), consisted of preterm patients who were p36 weeks GA at birth and did not have a diagnosis of NEC during their stay in the Newborn Special Care Unit. They were matched to the cases based on GA at birth within 2 weeks, day of life at the time of diagnosis of the case and date of birth within 6 months.
Data collection
Medical records were reviewed by two individuals at two distinct time intervals, 2006-2007 and 2008 using similar data collection tools. Data was collected from the day of diagnosis (day 0), and retrospectively for the preceding 7 days, and included demographics, feeding data, medications, comorbidities, respiratory support, clinical presentation and course (physical exam, laboratory, radiographic and surgery data). A composite 'sickness score' was generated for each patient. Variables contributing to the score included presence of bacteremia (1 point), intraventricular hemorrhage greater than grade II (1 point), never reaching full feeds (1 point), vasopressor use (2 points) and ventilatory support provided trough endotracheal tube with either conventional or high-frequency oscillatory ventilation (2 points). All variables were assessed in the 7 days preceding diagnosis with the maximum possible score being 7, and were scored if it was present at any point in the 7-day interval preceding diagnosis. The score is weighted for vasopressor and highfrequency oscillatory ventilation use.
Statistical analysis
On the basis of epidemiological data from our unit, we hypothesized that over the 16-year study interval, we would have approximately 50 cases of NEC-T and match two to four NEC non-T and non-NEC controls in the aforementioned manner. Unadjusted and adjusted odds ratios (OR) and their 95% confidence intervals (CI) were estimated using (exact) conditional logistic regression to evaluate associations between individual demographic and clinical characteristics and the risk of NEC-T. Variables found to be significantly associated with NEC-T in the univariate analyses were investigated further by building multivariate models. All analysis was performed using SAS Version 9.2 (SAS Institute, Cary, NC, USA), with statistical significance set at P-values less than 0.05 using two-sided tests.
This study was approved by the Human Investigation Committee of the Yale University School of Medicine.
Results
Study patients
In total, 14 075 infants were admitted to the Newborn Special Care Unit at Yale New Haven Children's Hospital during the 16-year study interval. A total of 328 (2.3%) patients had a diagnosis of NECXBell's Stage II. Of these, 132 (40.2%) patients had medical NEC, managed with bowel rest, antibiotics and GI decompression with an orogastric tube. Specifically, patients with medical NEC did not undergo exploratory laparotomy, intestinal resection or peritoneal drain placed as part of the management of NEC. Overall, 196 patients (59.8%) had surgical NEC, requiring laparotomy, intestinal resection or placement of a drain, in addition to the aforementioned medical management of NEC. In total, 42 (12.8%) patients had a diagnosis of NEC-T observed during surgery or autopsy; 39 of all NEC patients (11.9%) met case criteria for our study. Three patients were excluded; one had omphalocele, one had gastroschisis and one was >36 weeks GA at birth with a cardiac defect. Overall, 55 patients were excluded. Out of 352 patients, 297 were included in the final analysis: 39 NEC-T cases, 148 Group I controls and 110 Group II controls (Figure 1 ).
Group characteristics
Demographic and perinatal data. We found no significant differences between the three groups in race (as identified by mother) or gender. NEC-T patients were statistically more likely to be of Hispanic ethnicity with younger mothers. In the comparison of NEC-T and non-NEC patients, NEC-T patients were more likely to have a lower GA, lower birth weight, have intrauterine growth retardation and were more likely to be born at an outside institution (Tables 1 and 2 ).
Feeding. In the comparison between NEC-T and NEC non-T subjects, NEC-T subjects were more likely to have received higher enteral total fluid volume and calories, have reached full enteral feeds (defined as enteral feeds of at least 120 cc kg À1 per day and no use of parenteral nutrition), and have less feeding interruptions than NEC non-T patients. NEC-T patients were more likely to receive more formula feedings, receive higher enteral feeding volume and calories, achieve full enteral feeds, and have less feeding interruptions than their non-NEC counterparts at the time of diagnosis (Tables 1 and 2 ).
Physical, lab and radiography results. There were no significant differences in sickness scores between the three groups.
There were few significant differences in physical examination, laboratory results (including blood gases), white blood cell and platelet count or abdominal radiography in the 7 days preceding the day of diagnosis of NEC. Abdominal distention was documented more frequently in NEC-T patients in the days before diagnosis ((OR) ¼ 6.5, 95% CI of OR ¼ 2.1-20.4, P ¼ 0.001) in our comparison of NEC-T and non-NEC patients (other data not shown). When compared with non-NEC patients, NEC-T patients were statistically more likely to have received a red cell transfusion in the 7 days preceding diagnosis (Tables 1 and 2 ).
In the comparison of NEC-T and NEC non-T groups using multivariate conditional logistic regression, being inborn and receiving breast milk (including human milk fortifiers) for X4/7 days before diagnosis were associated with NEC non-T status. In addition, we analyzed our data to see whether the association of use of breast milk and decreased frequency of NEC-T was because of the effect of feeding or because of breast milk usage itself. For NEC-T vs NEC non-T, formula feeding for X4/7 days was not statistically associated with decreased risk of NEC-T (OR ¼ 2.88, P ¼ 0.033, 95% CI ¼ 0.34-24.1). After adjusting for other factors, achieving higher enteral feeding volumes was associated with an increased incidence of NEC-T. When NEC-T patients and non-NEC patients were compared with a similar approach, being an inborn patient, having higher GA and maternal age and being fed predominantly breast milk were significantly associated with non-NEC status. Formula feeding did not significantly decrease the risk of NEC-T significantly when the NEC-T group was compared with the non-NEC group (OR ¼ 2.33, P ¼ 0.46, 95% CI ¼ 0. 25-21.95 ). When other factors were held at a fixed value, reaching full enteral feeds before the day of diagnosis of NEC was associated with an increased rate of NEC-T (Table 3 ).
Discussion
We determined that there are few significant differences in the presentation of NEC-T and NEC non-T with respect to demographics, physical examination findings and laboratory values. We did observe, however, that NEC-T was associated with lower maternal age, Hispanic ethnicity, reaching full enteral feedings, achieving higher feeding volumes, higher caloric supplementation and having less feeding interruptions when compared with their NEC non-T matched controls.
For the purpose of this study, NEC-T was defined as necrosis of X80% of the intestinal tract noted on direct observation through surgery or autopsy. The clinical management and definition of NEC-T may vary by institution. In our institution, a surgical diagnosis of fulminant NEC or NEC-T was managed in one of two ways, either by withdrawal of life support or, with bowel resection and continued intensive care support.
Despite the marked difference in disease severity and outcome of NEC-T versus NEC non-T, we observed remarkably few clinical differences in these two groups of patients. NEC-T is typically a Risk factors for necrotizing enterocolitis totalis A Thompson et al 
rapid onset fulminant process that occurs with little to no warning. The pathophysiology of NEC -T is poorly understood. Are there subtle variations in intestinal vascular anatomy that predispose to it? Are there differences in the presentation of disease that might alter patient management, in advance of the rapid clinical deterioration? There is some evidence to suggest that genetic differences may predispose to development of NEC and that its' incidence may be increased in siblings and twins. [22] [23] [24] [25] It is conceivable that patients who develop NEC-T have a genetic predisposition to worse disease despite the clinical similarity to matched controls at the onset of illness.
Despite variances in the definition and management of fulminant NEC or NEC-T, it is a disease that has serious implications for our preterm population. 1, 5, 26 We chose to study this disease because of its sudden, unpredictable, and usually catastrophic occurrence in the preterm population. NEC-T accounted for 12% of all NEC cases XBell's stage II, in patients p36 weeks GA at birth, over a 16-year interval at our institution. Hence, although NEC-T is not common, its impact is important.
Although several recent studies have attempted to elucidate risk factors for progressive NEC, none have looked specifically at NEC-T. In 2010, Christensen et al. 18 evaluated 118 patients with NEC Stage III, retrospectively for antecedents of the disease, hoping to make an argument for 'early treatment' or prophylaxis. They found that the first-recognized antecedents of NEC were nonspecific to GI pathology and that the rapid progression of the pathology did not provide sufficient time for prophylaxis.
In 2008, Moss et al. 17 attempted to delineate clinical predictors of NEC in a multi-institutional study. A total of 455 infants were evaluated prospectively. Although the majority of variables assessed did not specifically identify those neonates likely to have progressive disease, they identified three variables not previously described as being associated with disease progression: teenaged mother, cardiac compressions and resuscitative drugs at birth, and never receiving enteral feeds before diagnosis. In our study, younger maternal age also increased the risk of occurrence of NEC-T. Receipt of resuscitative drugs and chest compressions at birth were not significantly different between the three groups in our investigation, but this was limited by the overall occurrence of NEC-T in our Newborn Special Care Unit patient population. In this investigation, there were also relatively few patients who did not have any enteral nutrition initiated before diagnosis of NEC.
In 1998, Voss et al. 14 reviewed the records of 128 patients with surgical NEC. A total of 52 patients had rapid, severe disease, defined as fulminant NEC, all of whom died before discharge from the hospital. This study focused on the outcome and prognosis once disease had occurred, not predictive parameters before the onset of disease. A statistical difference in the pH and the base deficit initially and post resuscitation was observed, but not in white blood cell, platelet and blood culture results as found in our study.
We noted an increased risk of NEC-T in patients who received red cell transfusions, when compared with non-NEC patients, but not in NEC non-T patients. Other studies have noted a similar (2) and the least form of ventilatory support being via intubation or use of high frequency oscillatory ventilation (HFOV) in the preceding seven days before diagnosis (2) . Maximum possible score ¼ 7. However, the nature of this association remains to be fully explored; it is unclear that this is truly a causative relationship. It is possible that patients who are beginning to manifest systemic signs of illness are more likely to have laboratory tests performed and perhaps a lowered transfusion threshold is applied. Anecdotally, infants with NEC-T have been thought to be older, 'more stable' preterm patients before the sudden onset of NEC-T. Our data did not reveal significant differences in sickness scores among the three study populations in the 7 days preceding diagnosis. Hence, NEC-T patients were not more stable than NEC non-T or non-NEC patients before diagnosis. They were also not significantly older postnatally at the time of diagnosis.
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There was a higher frequency of Hispanic and Black ethnicity and decreased rates of breast milk usage for X4/7 days preceding diagnosis in the NEC-T group. Although the observation of ethnicity and breast milk usage may be linked as they pertain to risk of developing NEC-T, genetic variation may be a potential confounder of this finding. Our finding of increased susceptibility of Hispanic patients to NEC-T has been noted in at least one other study. In 2009, a study by Guner and colleagues in California noted an increased risk of death in Hispanic males with NEC. 29 It is Sickness score is a composite of bacteremia (1), IVH>grade II (1), never reaching full feeds (1), vasopressor use (2) and the least form of ventilatory support being via intubation or use of high-frequency oscillation (HFOV) in the preceding seven days before diagnosis (2) . Maximum possible score ¼ 7. In our multivariate comparisons of NEC-T and NEC non-T, formula feeding for the majority of a week before diagnosis was associated with increased incidence of NEC-T. Previous studies suggest that use of breast milk may decrease risk of NEC. [19] [20] [21] In 2007, Henderson et al. 30 attempted a systematic review of formula and breast milk for feeding preterm or low birth weight infants. The authors found no randomized trials of formula milk versus maternal (mother's own) breast milk for preterm infants. In 2010, Sullivan et al. 19 randomized 207 infants to one of the three groups: exclusive breast milk with human milk-based fortification done at 100 and 40 ml kg À1 per day, respectively, breast milk with bovinebased fortification, or preterm formula. They found a reduced rate of NECXStage II (OR ¼ 0.23, P ¼ 0.007) and of surgical NEC in the exclusive breast milk groups compared with the mixed and preterm formula group. Other studies have compared donor breast milk and formula milk for feeding preterm infants and found decreased rates of NEC in those infants fed donor breast milk. 31, 32 We noted a slightly increased incidence of NEC-T in patients who achieved higher enteral feeding volumes and those who reached full enteral feeds before diagnosis, compared with those who had not. There is some suggestion that prolonging trophic, or minimal enteral feedings may decrease the incidence of NEC, or at the very least not lead to an increase in the incidence of this disorder. 33, 34 Others suggest that, although trophic or minimal enteral feeds may be beneficial, rapid advancement of feeds may increase risk of NEC. 35 A Cochrane meta-analysis by Kennedy and Tyler, 36 last updated in 2007, could not specifically recommend early initiation of progressive enteral feeds. However, non-GI benefits to this feeding strategy were noted.
Although the data collection process in our study was comprehensive, it is limited to a single institution's experience, which may define and manage NEC-T or fulminant NEC differently from other institutions. In addition, our NEC-T cases were limited because of our desire to include only those patients who were objectively diagnosed by surgery or autopsy. Having two different data collectors may introduce bias, though every attempt was made to maintain similarities in the definition of the clinical parameters assessed. The historical nature of the data also limits us only to information that has been recorded in the chart. There are potential differences in the way staff record data over time. In addition, there may be important data that was not recorded for varying reasons.
Overall, we found few clinical parameters associated with the development of NEC-T in our investigation. There were no major clinical signs and symptoms that were significantly different between the NEC-T and NEC non-T groups in advance of the diagnosis of NEC. Until rapid clinical deterioration and surgery or death occurs, it remains extremely difficult to predict which patients will develop NEC-T or NEC non-T.
Conclusion
A comprehensive examination of demographic and clinical data in the 7 days preceding a diagnosis of NEC-T did not reveal predictive parameters for developing NEC-T, when compared with other preterm patients. The physical examination before the time of diagnosis was not significantly different between NEC-T and other NEC patients. Use of breast milk for the majority of the week before the diagnosis of NEC was significantly protective from development of NEC-T. Though there were some statistically significant differences in some feeding parameters, the vast majority of infants in our unit who are managed with our current feeding strategies do not develop severe NEC. This paucity of clinically differentiating parameters suggests the need to look beyond clinical presentation to appropriately stratify risk of developing NEC and identify which premature patients will succumb to the aggressive totalis variant.
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